Skip to main content
Sudeep Pharma Limited logo

Sudeep Pharma Limited — Investor Relations & Filings

Ticker · SUDEEPPHRM ISIN · INE0QPI01025 LEI · 335800ESH1W57DIPAN45 BSE.NS Manufacturing
Open in API
Filings indexed 78 across all filing types
Latest filing 2026-05-28 Call Transcript
Country IN India
Listing BSE.NS SUDEEPPHRM

About Sudeep Pharma Limited

https://www.sudeeppharma.com/

Sudeep Pharma Limited specializes in the manufacturing of mineral-based excipients and active pharmaceutical ingredients (APIs). The company’s core portfolio includes high-purity mineral salts such as Calcium Phosphates, Calcium Carbonate, and Calcium Sulfate, which are utilized as essential components in solid dosage formulations and nutritional supplements. These products function as diluents, binders, and mineral sources across various applications. The organization maintains advanced production facilities compliant with international quality standards, including GMP, USP, EP, and BP. A strategic partnership with JRS Pharma enhances its technical expertise and global supply chain capabilities. Sudeep Pharma focuses on providing high-quality, regulatory-compliant mineral solutions to meet the demands of global markets, emphasizing research, development, and stringent quality control processes.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document contains the full verbatim transcript of Sudeep Pharma’s Q4 & FY26 earnings conference call, including moderator instructions, management presentations, and question-and-answer sections. This corresponds directly to the definition of a Call Transcript (CT).
2026-05-28 English
Submission of Earnings Call Transcript for Q4 FY26.
Call Transcript Classification · 97% confidence The document contains the full text of the company’s Q4 & FY2026 earnings conference call, including speaker listings (Moderator, management team), Q&A format, and detailed operational and financial commentary. It is not an earnings release summary but the full transcript of the call. Therefore, it is classified as a Call Transcript.
2026-05-28 English
Submission of Annual Secretarial Compliance Report for FY 2025-26
Regulatory Filings Classification · 86% confidence The document is a letter submitted to stock exchanges under SEBI LODR Regulation 24A attaching the entity’s Annual Secretarial Compliance Report for the financial year ended March 31, 2026. It is not a financial performance report (e.g., 10-K or interim), nor a proxy, M&A, dividend, or earnings announcement. It is an attached compliance certificate under listing regulations, so it falls under general regulatory filings. Therefore, it should be classified as Regulatory Filings (RNS).
2026-05-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document is an intimation letter to stock exchanges under SEBI Listing Regulations (Regulation 30) disclosing the schedule of analyst/institutional investor meetings. It is a mandatory regulatory announcement and contains no financial statements, presentation slides, or transcripts. It does not fit into any specific category like earnings release, investor presentation, or management change, so it falls into the general Regulatory Filings category (RNS).
2026-05-23 English
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended from time to time, we herewith submit the participation of Company Officials ....
Regulatory Filings Classification · 85% confidence The document is an intimation under SEBI (Listing Obligations and Disclosure Requirements) Regulation 30, notifying stock exchanges of the schedule of analyst and institutional investor meetings. It does not contain financial results or substantive report content, nor is it a proxy, dividend notice, earnings release, or investor presentation. This is a regulatory announcement/disclosure under continuous listing obligations, fitting the general Regulatory Filings (RNS) category.
2026-05-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is an exchange filing under SEBI Listing Regulations notifying the stock exchanges that the audio recording of an earnings call has been uploaded to the company’s website. It does not contain any substantive financial data or the actual earnings release/transcript itself; it is a compliance announcement. Therefore, it fits the “Regulatory Filings (RNS)” category as a general regulatory announcement under listing rules.
2026-05-22 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.